TXT — Textron Inc.

The tape is the tell: as of 2026-09-13, TXT is down 8.9% over one month, 12.7% over three months and 11.0% over six months, sitting at $81 versus a 52-week low of $78.12 and below its 20-, 50- and 200-day moving averages. That decline happened despite a Q2 2026 (reported 2026-07-28) adjusted EPS beat of $1.62 versus $1.54 consensus and reiterated FY26 adjusted EPS guidance of $6.40-$6.60 - which tells you the market is punishing cash conversion and mix, not the earnings line. Manufacturing cash flow before pension contributions fell to $154M in Q2 2026 from $336M in Q2 2025, and the analyst consensus rating is a tepid 'Hold' even with a $96.50 average price target - a target/rating mismatch that reads as 'cheap but no reason to buy yet.'

Revenue is growing but decelerating. FY2024 revenue was $13.70B, FY2025 was $14.80B (+8.0%), and the last four quarterly YoY prints run +5.1% (Q3'25, $3.60B), +15.6% (Q4'25, $4.18B), +11.8% (Q1'26, $3.70B) and just +3.0% (Q2'26, $3.83B) - a clear slowdown into the most recent quarter, not a one-off blip. Earnings are steadier than the headline growth suggests: GAAP diluted EPS ran $1.31 / $1.32 / $1.25 / $1.42 over the trailing four quarters (TTM $5.30), improved from a depressed FY2024 of $4.32 that was dragged by the 2024-12-28 quarter (gross profit $901M with a $491M R&D line), and the accruals ratio of -0.31% as of 2026-06-30 confirms cash earnings are running ahead of reported net income. Margins are the soft spot and are flat, not expanding: excluding the anomalous 2026-01-03 quarter (negative $387M R&D line, gross margin 12.1% versus a ~17-18% norm), operating margin has oscillated between roughly 6.1% and 8.4% since early 2024, with Q2 2026 at 7.0% versus Q2 2025 at 7.2%. Verdict: stable-to-decelerating revenue, stable-but-thin margins, no structural inflection in either direction - this is neither a turnaround nor a collapse.

Cheap on every multiple the data supports, but cheap for identifiable reasons. As of 2026-09-13 at $81.00: TTM P/E 15.3x versus the 5-year average of 18.5x; P/S 0.91x versus the 5-year average of 1.17x; P/B 1.73x; EV/EBITDA 9.6x (a real discount to pure-play aerospace and defense comps, which typically trade in the low-to-mid teens); PEG 0.80. Forward math is the crux: 12.3-12.7x on the FY26 adjusted EPS guide of $6.40-$6.60, but 14.5-15.0x on GAAP EPS from continuing operations of $5.39-$5.59. So the 'cheap' label depends entirely on whether the ~$1.00/share gap between GAAP and adjusted is genuinely one-off divestiture cost. This is a value multiple attached to a below-average-quality business - ROIC of 5.9% is below any reasonable cost of capital estimate, and net margin is 6.1% - so the discount is warranted, not a mispricing.

The stock is trading on cash flow and quality, not on EPS. Q2 2026 beat on adjusted EPS ($1.62 versus $1.54) and management reiterated FY26 guidance, yet the shares fell 12.7% over three months - the market is re-rating the cash conversion (manufacturing cash flow of $154M versus $336M a year earlier) and the thin ~7% clean operating margin. The number to anchor on is the GAAP-versus-adjusted spread: $5.39-$5.59 GAAP continuing ops versus $6.40-$6.60 adjusted implies ~$1.00/share of charges. If those prove to be genuine one-time Industrial-divestiture costs, the stock at 12.5x adjusted EPS is underpricing a pure-play aerospace and defense re-rating. If they recur in Q3 and Q4 2026, the stock is fairly valued at ~15x GAAP and there is no re-rating to come. Practical read: do not treat the earnings beat as the signal; treat the Q3 2026 manufacturing cash flow print (reporting ~2026-10-22) as the signal.

Clearly a downtrend, not a bottom. As of 2026-09-13, RSI(14) sat at 41.54 - weak-leaning but nowhere near oversold, so there is no capitulation signal for value buyers - and the price of $81.00 was 1.68% below its 20-day SMA (~$82.4), 6.85% below its 50-day SMA (~$87.0) and 10.04% below its 200-day SMA (~$90.0). The 52-week range is $78.12-$101.57, so the shares are pinned near the low end with a modest bounce underway (+2.44% over the last week). Implication for entry timing: there is no urgency. A reclaim of the 50-day SMA near $87 would be the first real confirmation that the downtrend is breaking; a push back under $78.12 would likely mean the market is pricing in a guidance cut before management delivers one.

• Defense budgets and geopolitical tension support Bell and Textron Systems, but fixed-price development programs like the MV-75 Cheyenne are audited tightly and any cost overrun hits margins directly.
• Business jet demand is tied to corporate capex and fractional fleet buying (NetJets took the first five Citation Ascends) - solid now, but discretionary and sensitive to macro confidence.
• Interest rates cut both ways: they raise aircraft financing costs for customers and increase pension obligation dynamics, both headwinds for Textron Aviation and free cash flow.
• The shift to a pure-play aerospace and defense platform should re-rate the multiple toward higher-multiple A&D peers, but the conglomerate discount persists until a buyer and price are announced.
• Aerospace supply chain and labor cost inflation pressure the ~7% clean operating margin, where Textron has far less cushion than its large-cap A&D peers.

• Q3 2026 earnings, expected around 2026-10-22 - the key checkpoint is whether manufacturing cash flow normalizes toward the ~$336M quarterly run rate seen in 2025, plus any change to the $6.40-$6.60 adjusted EPS guidance.
• Announcement of a buyer and price for the Industrial segment sale (process advanced in Q2 2026) - terms and the use of proceeds (buybacks ran $209M in Q2 2026) drive the re-rating case.
• Bell MV-75 Cheyenne program milestones and defense contract awards, which would validate the pure-play defense narrative.
• Continued business jet order momentum and Citation Ascend delivery ramp, the main organic revenue driver.
• Q3 GAAP-versus-adjusted EPS spread - if the ~$1.00/share gap narrows, the market can start valuing the company off adjusted earnings.

• Cash conversion deterioration: Q2 2026 manufacturing cash flow fell to $154M from $336M a year earlier, and free cash flow was -$250M in the 2026-04-04 quarter and only $209M in Q2 - lumpy FCF undermines the buyback-and-dividend story.
• Structurally low returns: ROIC of 5.9% and a clean operating margin near 7% mean Textron earns less than its cost of capital, leaving no buffer if business jet or defense volumes soften.
• Divestiture execution risk: a slow sale, a low price, or stranded corporate costs after the Industrial exit could leave shareholders with a smaller, still-discounted company.
• Business jet cyclicality: a corporate capex downturn would hit the highest-margin segment, and the stock is already near 52-week lows with no valuation floor proven.
• Defense program execution on development contracts (MV-75) and the risk that the GAAP-to-adjusted EPS gap recurs in future quarters, forcing guidance lower.

Textron is a cheap, not-yet-good business. At $81 as of 2026-09-13 you are paying 12.5x guided adjusted FY26 earnings, 9.6x EV/EBITDA and about 5.4% on TTM free cash flow of $759M for an aerospace and defense asset - genuinely inexpensive on absolute and own-history terms - but you are buying 5.9% ROIC, ~7% clean operating margins, decelerating revenue growth (+3.0% YoY in Q2 2026), and a cash conversion problem the market has been correctly punishing. The bull case rests entirely on the Industrial divestiture closing at a decent price and the market re-rating a pure-play Bell/Textron Aviation/Systems company toward A&D peer multiples; the bear case is that the GAAP-to-adjusted EPS gap keeps recurring and the 'cheap' stock stays cheap. With no oversold technical signal (RSI 41.5) and Q3 cash flow not due until ~2026-10-22, the honest position is Neutral: own it for the eventual re-rating if you are patient, but there is no evidence yet that the earnings power or cash generation has inflected.

Method: 14x forward adjusted EPS of $6.50 (midpoint of FY26 guidance of $6.40-$6.60, consistent with the $6.466 next-FY consensus estimate) = $91.00. The 14x is a deliberate discount to Textron's own 5-year average P/E of 18.54 (inflated by charge-depressed 2024 GAAP earnings) and to A&D peers, justified by 5.9% ROIC and a ~7% clean operating margin; cross-checks support it - 10.5x EV/EBITDA on roughly $1.64B of EBITDA less $1.84B net debt gives ~$90/share, and a 6% required FCF yield on normalized free cash flow of ~$900M gives ~$87/share. Final figure is $91.